GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (OTCPK:ASAPF) » Definitions » YoY EBITDA Growth

ASAPF (Aurora Spine) YoY EBITDA Growth : -500.00% (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Aurora Spine's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -500.00%.

Aurora Spine's EBITDA per Share for the three months ended in Dec. 2024 was $-0.00.

Aurora Spine YoY EBITDA Growth Historical Data

The historical data trend for Aurora Spine's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine YoY EBITDA Growth Chart

Aurora Spine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.67 -136.36 73.08 14.29 133.33

Aurora Spine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 114.29 116.67 133.33 400.00 -500.00

Aurora Spine YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Aurora Spine's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.002--0.006)/ | -0.006 |
=133.33 %

Aurora Spine's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.004-0.001)/ | 0.001 |
=-500.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Aurora Spine's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Aurora Spine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (OTCPK:ASAPF) » Definitions » YoY EBITDA Growth
Comparable Companies
TSXV:VPT TSXV:MDX TSXV:PINK TSXV:NGMD TSXV:CNVI TSXV:THRM TSXV:FREQ TSXV:TLT TSXV:ZCT XCNQ:PMED ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
ASG:Canada
Address
20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Website
https://www.aurora-spine.com
Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.